Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Depression

Anhedonia: New study provides insight into an overlooked but very common symptom of depression

by Ciara McCabe
August 14, 2023
in Depression
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

It’s often thought that if someone is depressed, they will feel sad or low most of the time. But what many don’t realise is that these aren’t the only symptoms of depression. Another common symptom of depression that is sometimes overlooked is the feeling that you no longer find the things you used to enjoy to be interesting or pleasurable.

Known as anhedonia, this symptom is present in up to 75% of adults and young people with depression. But despite how common this symptom is, it remains one of the most difficult symptoms to treat and manage.

Loss of pleasure

Anhedonia is defined as the reduced interest or pleasure in all – or almost all – activities a person previously enjoyed. If a person has anhedonia for an extended period of time (at least two weeks consistently), they can be diagnosed with depression – even if they may not feel sad or low.

Although mainly associated with depression, anhedonia can also be a symptom of other disorders – such as schizophrenia, anxiety and Parkinson’s disease.

In in-depth interviews my colleagues and I conducted with young people about depression, anhedonia was described by many as not just a loss of joy, but also less motivation to do things. For some, this lack of drive was only related to specific things – such as going to school or seeing friends. But for others, it was more severe, and they felt they didn’t want to do anything at all – not even live.

But despite how troubling anhedonia can be, it’s often not the main target of depression treatment.

It’s recommended that cases of mild depression are treated with talking therapy. People with more moderate or severe cases of depression may be prescribed antidepressants. While all these treatments aim to help patients cope with and overcome symptoms, over half of people with depression don’t respond to their first recommended treatment. Even after changing treatments, approximately 30% of patients still experience symptoms.

It’s been argued that one reason for these low response rates may be because current treatment techniques don’t adequately target anhedonia. Research also shows that having anhedonia predicts chronic relapsing of depression. It’s even possible that some antidepressant treatments might make anhedonia worse.

Why might this be? One possibility is that current standard treatments focus mainly on treating the depressed mood and brain processes that underpin low mood – but not anhedonia. For example the main aim of talking therapies, such as cognitive behavioural therapy, is to reduce negative thinking in patients. The most common antidepressant medications also mainly target serotonin, which is thought to underpin in part, how the brain processes negative information.

But as anhedonia is reduced joy in life, treatments such as behavioural activation (a form of talking therapy) could be better for anhedonia. This is because behavioural activation aims to help people with depression take simple, practical steps towards enjoying life again. Yet some studies find behavioural activation is no better than standard treatments in managing anhedonia. This might be because the very nature of anhedonia includes a lack of motivation – making it difficult for patients to engage in any therapy, even forms which may most benefit them.

Anhedonia has also been linked to dysfunctional reward mechanisms in the brain. As such, treatments which focus more on improving the way the brain processes reward could help alleviate anhedonia more effectively than current treatments.

But the brain’s reward system isn’t straightforward, and actually involves various subprocesses – including anticipation, motivation, pleasure and learning about reward. Problems with any one of these subprocesses could be contributing to anhedonia. As such, it will be important for research to uncover how these subprocesses operate in people with anhedonia to develop better targets for treatment.

Treatment options

While anhedonia may be complex, that doesn’t mean there’s no hope for those who are affected by it.

For instance, research shows that talking therapies which focus on reward processing could help reduce anhedonia. A recent pilot study also found that a new type of talk therapy called augmented depression therapy may work better than cognitive behavioural therapy in treating depression. This is because augmented depression therapy specifically targets anhedonia by having patients focus on both their negative and positive experiences.

Further, antidepressants that target neurotransmitters involved in the reward system (such as dopamine) might be better suited for patients with anhedonia. Early work examining drugs such as ketamine, which can affect dopamine activity, suggest it may have promise for treating anhedonia.

And while it can be hard to find motivation if you’re experiencing anhedonia, trying to find time for fun, enjoyable activities or experiences like a hobby you used to love – or even a new hobby – could help alleviate anhedonia.

If you think you have anhedonia – or other symptoms of depression – it’s important not to ignore your feelings so you can get the help and treatment you deserve. If you aren’t sure where to begin, you could try sharing how you feel with a loved one or with your GP.

You could also contact Samaritans – call 116 123 or email [email protected] if you need to talk to someone soon. It’s free and anonymous.The Conversation

 

 

This article is republished from The Conversation under a Creative Commons license. Read the original article.

RELATED

Surprising link found between aesthetic chills and political extremism
Anxiety

Single dose of psilocybin provides lasting relief from depression and anxiety in cancer patients

August 27, 2025

Cancer patients with major depression experienced significant and long-lasting improvements after just one psilocybin session, according to new research. Two years later, many showed continued reductions in depression and anxiety, with some requiring no further treatment or medication.

Read moreDetails
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Depression

Antidepressant withdrawal symptoms may be more common and more severe than some studies suggest

August 22, 2025

A new study challenges previous claims that antidepressant withdrawal is rare or mild. Researchers found that more than half of patients report symptoms when discontinuing, suggesting earlier reviews relying on short-term trials may have underestimated the risks.

Read moreDetails
The neurobiology of trauma: How childhood adversity alters brain development
Depression

Esketamine nasal spray shows rapid antidepressant effects as standalone treatment

August 16, 2025

A new clinical trial suggests that esketamine nasal spray, used alone without oral antidepressants, may reduce depressive symptoms in patients with treatment-resistant depression. The fast-acting treatment showed benefits within 24 hours and sustained effects over four weeks.

Read moreDetails
Specific narcissistic traits appear to heighten veteran PTSD risk
Depression

Depressed individuals have heightened C-reactive protein-to-albumin ratio

August 13, 2025

New research links an elevated C-reactive protein-to-albumin ratio—a blood marker reflecting inflammation and nutrition status—to higher odds of depression. The findings raise the possibility that this widely available biomarker could play a role in mental health screening.

Read moreDetails
Dark Triad personality traits linked to more favorable attitudes toward cognitive enhancement
Alzheimer's Disease

Antidepressant vortioxetine linked to greater cognitive and mood improvements in Alzheimer’s patients

August 9, 2025

A year-long study suggests vortioxetine may offer greater improvements in both cognition and mood for people with Alzheimer’s disease and depression compared to other antidepressants, potentially making it a promising treatment option alongside standard Alzheimer’s therapies.

Read moreDetails
New neuroscience research reveals the remarkable impact of exercise on brain cells
Depression

Neuroscientists make fascinating breakthrough linking disinhibited brain networks to depression

August 6, 2025

Neuroscientists used rare intracranial recordings to trace how moment-to-moment brain activity in the prefrontal cortex reflects daily mood changes. They found that depression worsens as cortical communication becomes disinhibited and hemispheric activity grows increasingly imbalanced.

Read moreDetails
Neuroscientists pinpoint part of the brain that deciphers memory from new experience
Depression

Amygdala enlargement linked to future onset of depression

August 5, 2025

A new study found that structural brain differences—specifically in the amygdala—may predict who will develop depression. These changes were present before symptoms began, suggesting a possible early biomarker for identifying individuals at elevated risk for first-time depressive episodes.

Read moreDetails
Depressed individuals who feel stigmatized are more likely to contemplate suicide
Depression

Depressed individuals who feel stigmatized are more likely to contemplate suicide

July 29, 2025

A new study has found that people with depression who internalize stigma are more likely to experience suicidal thoughts. The findings highlight how shame and self-judgment can intensify suicidal ideation, independent of depression severity.

Read moreDetails

STAY CONNECTED

LATEST

New research shows people shift moral arguments to fit their stance on women’s bodies

Students whose parents were warmer towards them tend to have better socio-emotional skills

Scientists link immune markers to mental health symptoms in children with chronic illness

Even in secular Denmark, supernatural beliefs remain surprisingly common, study finds

A major new study charts the surprising ways people weigh AI’s risks and benefits

Study links phubbing sensitivity to attachment patterns in romantic couples

A common childhood virus could be silently fueling Alzheimer’s disease in old age

It’s not social media: What’s really fueling Trump shooting conspiracies might surprise you

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy